News

June 5, 2019June 5, 2019

Use of Antihypertensives Doesn’t Decrease vEDS Complications, Study Suggests

News

The use of antihypertensive therapies — medications that lower high blood pressure — is not linked to a decrease in the frequency of clinical events associated with vascular Ehlers-Danlos ... Read more

May 29, 2019May 29, 2019

Ehlers-Danlos Society Awards $275K in Grants to Support Research on EDS and HSD

News

The Ehlers-Danlos Society will award a total $275,000 in research grants to four projects seeking to advance knowledge of Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD), and improve the quality ... Read more

May 27, 2019May 27, 2019

Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries

News

RaDaR, the catchy new name for the U.S. government-run Rare Diseases Registry Program, aims to help patient advocacy groups with limited resources build their own disease registries. The site ... Read more

May 22, 2019May 22, 2019

Ehlers-Danlos Society Marks Awareness Month in May with Variety of Awareness, Fundraising Initiatives

News

The Ehlers-Danlos Society is offering several ways to get involved, spread awareness, and raise funds during Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder Awareness Month in May. Through a mix of individual ... Read more

May 15, 2019May 15, 2019

Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns

News

With 250 rare diseases newly identified every year, scientists can barely keep up — even as the healthcare system fails millions of Americans whose rare diseases have already been ... Read more

May 1, 2019May 1, 2019

PALS Uplifts the Spirits of Rare-Disease Patients by Offering Free Flights

News

Cumbersome security procedures, rising airfares, and shrinking legroom have made commercial air travel difficult enough these days — even for healthy passengers. Imagine how much harder it is for ... Read more

April 24, 2019April 24, 2019

Celiprolol, Not Losartan, Improves Aortic Strength in Mouse Model of vEDS

News

Celiprolol, a therapy that improves heart rate and reduces blood pressure, can strengthen the aortic walls in a mouse model of vascular Ehlers-Danlos syndrome (vEDS), preventing the aorta from ... Read more

April 17, 2019April 17, 2019

Celiprolol Treatment Linked to Improved Survival in vEDS Patients

News

The therapy celiprolol increased the survival rate and possibly lowered annual incidence of arterial events in patients with vascular Ehlers-Danlos syndrome (vEDS), according to results of a long-term study ... Read more

April 10, 2019

Almost Half of EDS/HSD Patients Have Psychiatric Disorders, Canadian Study Finds

News

Psychiatric disorders, namely depression, may affect almost half of patients with Ehlers–Danlos syndromes (EDS) and hypermobility spectrum disorder (HSD). Also, mental health problems may be associated with pain and gastrointestinal ... Read more

April 4, 2019April 4, 2019

Evaluating Shoulder Movement May Help Diagnose Joint Hypermobility in EDS, Study Finds

News

Evaluation of the ability of a person to move his or her shoulder with an upward arm movement could help demonstrate joint hypermobility associated with Ehlers-Danlos syndrome (EDS), a ... Read more

Pin It on Pinterest